Abstracts Archive - Page 1153 of 1683 - ATC Abstracts

2017 American Transplant Congress
Serum Alkaline Phosphatase Predicts Graft Failure and Mortality in Kidney Transplant Recipients.
Y. Kim,¹ S. Park,¹ S. Yang,² H. Lee,¹ Y. Kim,³ S.-K. Park,⁴ D. Han,³ I. Jung,⁵ J. Ha,⁶ C. Lim,⁷ Y. Kim,¹ J. Lee.⁷
¹Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; ²Seoul National University Biomedical Research Institute, Seoul, Republic of Korea; ³Division of Kidney Transplantation, Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁴Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁵Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; ⁶Surgery, Seoul National University Hospital, Seoul, Republic of Korea; ⁷Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea
Objective: Recent studies showed that high levels of serum alkaline phosphatase (ALP) are associated with all-cause or cardiovascular death among hemodialysis patients. However, there are…
2017 American Transplant Congress
Impact of Non-Adherence in a Cohort of Kidney Transplant Recipients.
M. Merino-López,¹ C. Flores-Gama.²
¹National Autonomous University of Mexico, Mexico, Mexico; ²Nephrology, National Institute of Cardiology, Mexico, Mexico
Background: The understanding of the main causes of allograft losts and related factors is a critical in the sucess of kidney transplantation programs.Objective: The aim…
2017 American Transplant Congress
Allograft Crescent Predicts Graft Failure in Recurrent IgA Nephropathy Patients.
S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.
Seoul National University Hospital, Seoul, Korea
Background A recent multicenter study demonstrates predictive value of crescents in native IgA nephropathy (IgAN), however it remains unclear whether allograft crescent is associated with…
2017 American Transplant Congress
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Trasplant.
B. Rodriguez Cubillo, M. Calvo, V. Lopez De La Manzanara, J. Bautista-Cañas, I. Perez-Flores, M. Moreno De La Higuera, N. Calvo Romero, A. Sanchez-Fructuoso.
Nephrologist, Hospital Clínico San Carlos, Madrid, Spain
BACKGROUND: Renal transplantation has been established as the treatment of choice for end-stage renal disease (ESRD) due to diabetic nephropathy. This study aimed to investigate…
2017 American Transplant Congress
Deceased Donor-Initiated Non-Simultaneous Extended Altruistic Donor Chains Through the Military Share Program.
M. Rees,^1,2 O. Ekwenna,¹ E. Elster,³ A. Patel,³ D. Murtagh, Jr,¹ A. Roth,⁴ K. Krawiec,⁵ J. Arrington,⁶ I. Ashlagi,⁴ J. Hawksworth.³
¹U Toledo, Toledo, OH; ²Alliance for Paired Donation, Perrysburg, OH; ³Walter Reed National Medical Center, Bethesda, MD; ⁴Stanford U, Palo Alto, CA; ⁵Duke U, Durham, NC; ⁶Buckeye Transplant, Findlay, OH
Introduction: At a recent White House Summit on organ transplantation, the Department of Defense (DoD) announced that they would direct some Military Share deceased donor…
2017 American Transplant Congress
Perceived Legitimacy of Using Social Support for Transplant Eligibility: Results from a National Survey of Transplant Clinicians.
K. Ladin,¹ E. Gordon,² Z. Butt,² T. Lavelle,¹ N. Daniels,³ D. Hanto.⁴
¹Tufts University, Medford, MA; ²Northwestern University School of Medicine, Chicago; ³Harvard University, Boston; ⁴Vanderbilt University School of Medicine, Nashville
Background: Although the Centers for Medicare and Medicaid Services require that social support be used to determine transplant eligibility, guidance is vague. Centers vary significantly…
2017 American Transplant Congress
Screening and Referral of High Risk Liver Transplant Recipients to a Transitional Care Coordination (TCC) Program to Reduce Hospital Readmissions.
A. Masoumi,¹ J. Krzyzewski,¹ T. Stern,¹ N. Schluterman,² D. Bruno,² J. Bromberg,² R. Barth,² S. Hanish.²
¹University of Maryland Medical Center, Baltimore, MD; ²University of Maryland School of Medicine, Baltimore, MD
Introduction One-fifth of Medicare patients are readmitted to the hospital. The readmission rate among liver transplant recipients at a large tertiary academic medical center in…
2017 American Transplant Congress
The Incremental of Cost of Incompatible Living Donor Kidney Transplant: A National Cohort Analysis.
D. Axelrod,¹ K. Lentine,² M. Schnitzler,² H. Xiao,² X. Lou,³ B. Orandi,³ J. Garonzik Wang,³ A. Massie,³ D. Segev.³
¹Surgery, East Carolina University, Greenville, NC; ²Transplant, Saint Louis University, St. Louis, MO; ³Surgery, Johns Hopkins University, Baltimore, MD
Incompatible living donor kidney transplant (ILDKT) has been established as an effective option for patients with willing but human leukocyte antigen incompatible live donors, reducing…
2017 American Transplant Congress
A Markov Model for Transplant & Renal Outcomes After Liver & Simultaneous Liver-Kidney Transplants.
X. Cheng,¹ W. Kim,² J. Tan,¹ J. Goldhaber-Fiebert.³
¹Div Nephrology, Stanford U, Palo Alto; ²Div Gastroenterology & Hepatology, Stanford U, Palo Alto; ³Ctr Health Policy, Stanford U, Palo Alto
The Organ Procurement and Transplant Network (OPTN) will implement a set of clinical criteria for simultaneous liver-kidney (SLK) transplant eligibility. Our aim is to build…
2017 American Transplant Congress
State Law Restrictions on HIV Positive-to-Positive Transplantation.
S. Rasmussen,¹ A. Glazier,² A. Cash,¹ M. Henderson,¹ B. Boyarsky,¹ K. Miller,³ S. Schoettes,⁴ D. Segev,¹ C. Durand.¹
¹JHU, Baltimore; ²NEOB, Waltham; ³HIV Medicine Association, Arlington; ⁴Lambda Legal, Chicago
Background In 1984 the National Organ Transplant Act banned the recovery of organs from HIV-positive (HIV+) individuals. In 2013 the HIV Organ Policy Equity (HOPE)…